4.0(top 10%)
impact factor
1.4K(top 20%)
papers
9.2K(top 20%)
citations
34(top 20%)
h-index
4.1(top 10%)
extended IF
1.5K
all documents
11.9K
doc citations
50(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Frequent neurocognitive deficits after recovery from mild COVID-19Brain Communications2020236
2The orbitofrontal cortex: reward, emotion and depressionBrain Communications2020169
3The cognitive consequences of the COVID-19 epidemic: collateral damage?Brain Communications2020151
4Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysisBrain Communications2022147
5Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomesBrain Communications202098
6The role of the medial prefrontal cortex in cognition, ageing and dementiaBrain Communications202197
7Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypesBrain Communications202081
8Rapid vigilance and episodic memory decrements in COVID-19 survivorsBrain Communications202272
9Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary preventionBrain Communications202069
10Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease riskBrain Communications201967
11Circadian and multiday seizure periodicities, and seizure clusters in canine epilepsyBrain Communications202063
12Neuroimaging in Parkinson’s disease dementia: connecting the dotsBrain Communications201962
13Mechanical property alterations across the cerebral cortex due to Alzheimer’s diseaseBrain Communications202057
14Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 yearsBrain Communications202257
15TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patientsBrain Communications202055
16Disentangling white-matter damage from physiological fibre orientation dispersion in multiple sclerosisBrain Communications202055
17Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responsesBrain Communications202053
18Is tau in the absence of amyloid on the Alzheimer’s continuum?: A study of discordant PET positivityBrain Communications202053
19Epilepsy in the mTORopathies: opportunities for precision medicineBrain Communications202153
20Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?Brain Communications202052
21White matter hyperintensities are common in midlife and already associated with cognitive declineBrain Communications201951
22Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathyBrain Communications202051
23Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkersBrain Communications202151
24Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs developmentBrain Communications201949
25Restoring regulatory T-cell dysfunction in Alzheimer’s disease through ex vivo expansionBrain Communications202048
26Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort studyBrain Communications202148
27Cerebrovascular disease promotes tau pathology in Alzheimer’s diseaseBrain Communications202046
2811β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trialBrain Communications202046
29Increased weighting on prior knowledge in Lewy body-associated visual hallucinationsBrain Communications201945
30Objective interictal electrophysiology biomarkers optimize prediction of epilepsy surgery outcomeBrain Communications202145
31A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOEBrain Communications202045
32Current knowledge of SLC6A1-related neurodevelopmental disordersBrain Communications202044
33Genome-wide association studies for Alzheimer’s disease: bigger is not always betterBrain Communications202244
34Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromesBrain Communications202143
35Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriersBrain Communications201942
36Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brainBrain Communications202142
37Quantifying bias in psychological and physical health in the UK Biobank imaging sub-sampleBrain Communications202242
38Artificial intelligence for clinical decision support in neurologyBrain Communications202041
39High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage displayBrain Communications202041
40Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptorBrain Communications202141
41Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucomaBrain Communications201940
42Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobinBrain Communications202039
43Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosisBrain Communications202139
44Diffusion models reveal white matter microstructural changes with ageing, pathology and cognitionBrain Communications202138
45Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tauBrain Communications202037
46Acetyl-leucine slows disease progression in lysosomal storage disordersBrain Communications202137
47Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodiesBrain Communications202137
48Midbrain organoids with anSNCAgene triplication model key features of synucleinopathyBrain Communications202137
49Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathiesBrain Communications202136
50Chronic subthreshold cortical stimulation and stimulation-related EEG biomarkers for focal epilepsyBrain Communications201935